Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study.
Rothnie KJ, Wood RP, Czira A, Banks VL, Camidge LJ, Massey OKI, Seif M, Compton C, Sharma R, Halpin DMG, Ismaila AS, Vogelmeier CF. Rothnie KJ, et al. Among authors: czira a. BMJ Open Respir Res. 2024 May 21;11(1):e001890. doi: 10.1136/bmjresp-2023-001890. BMJ Open Respir Res. 2024. PMID: 38772900 Free PMC article.
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Ismaila AS, Rothnie KJ, Wood RP, Banks VL, Camidge LJ, Czira A, Compton C, Sharma R, Millard SN, Massey O, Halpin DMG. Ismaila AS, et al. Among authors: czira a. Respir Res. 2024 Apr 1;25(1):152. doi: 10.1186/s12931-024-02745-x. Respir Res. 2024. PMID: 38561735 Free PMC article. No abstract available.
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.
Czira A, Akiyama S, Ishii T, Wood RP, Camidge LJ, Wallis H, Jennison T, Wild RAC, Yarita M, Hashimoto K, Rothnie KJ, Ismaila AS. Czira A, et al. Int J Chron Obstruct Pulmon Dis. 2023 Dec 8;18:2933-2953. doi: 10.2147/COPD.S419119. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 38089540 Free PMC article.
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Ismaila AS, Rothnie KJ, Wood RP, Banks VL, Camidge LJ, Czira A, Compton C, Sharma R, Millard SN, Massey O, Halpin DMG. Ismaila AS, et al. Among authors: czira a. Respir Res. 2023 Sep 25;24(1):229. doi: 10.1186/s12931-023-02523-1. Respir Res. 2023. PMID: 37749551 Free PMC article.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England.
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJF, Quint JK, Ismaila AS. Requena G, et al. Among authors: czira a. Int J Chron Obstruct Pulmon Dis. 2023 Sep 15;18:2039-2054. doi: 10.2147/COPD.S408688. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37731774 Free PMC article.
21 results